Table 2 Comorbidities in the studied groups
Group | Chi-square | |||||
|---|---|---|---|---|---|---|
Vitamin K1 | Vitamin K2 | Placebo | ||||
N (%) | N (%) | N (%) | X2 | P-value | ||
HTN | No | 11 (27.5) | 11 (27.5) | 12 (30) | 0.1 | 1 |
Yes | 29 (72.5) | 29 (72.5) | 28 (70) | |||
DM | No | 31 (77.5) | 31 (77.5) | 26 (65) | 2.1 | 0.3 |
Yes | 9 (22.5) | 9 (22.5) | 14 (35) | |||
HCV | No | 32 (80) | 33 (82.5) | 35 (87.5) | 0.8 | 0.7 |
Yes | 8 (20) | 7 (17.5) | 5 (12.5) | |||
Smoking | No | 31 (77.5) | 33 (82.5) | 32 (80) | 0.3 | 0.9 |
Yes | 9 (22.5) | 7 (17.5) | 8 (20) | |||
Heart failure | No | 34 (85) | 31 (77.5) | 33 (82.5) | 0.8 | 0.7 |
Yes | 6 (15) | 9 (22.5) | 7 (17.5) | |||
ISHD | No | 37 (92.5) | 35 (87.5) | 36 (90) | 0.6 | 0.8 |